Navigation Links
June 2008 Mayo Clinic Women's HealthSource Highlights Shingles Vaccine for Pain Prevention, Tips to Avoid Antibiotic Resistant Infections, and Benefits of Broad Genetic Testing
Date:6/24/2008

hes after each use.

Get infections tested: If an infection requires treatment, ask the care provider to take a culture to confirm what bacteria are present before you are given an antibiotic. If you test positive for a staphylococcus (staph) infection, ask that a culture be tested specifically for MRSA in case you need a special antibiotic.

Use antibiotics appropriately: When you take antibiotics, take all doses even when you start feeling better. Don't demand antibiotics for viral illnesses; antibiotics don't work with viruses. Taking too many antibiotics over time could become a detriment because the medication's effectiveness can be compromised by overuse.

Use antibacterial products sparingly: Antibacterial soaps and cleaning products probably don't prevent infections at home and may make these products less effective in hospitals.

Take precautions in the hospital: Ask all hospital staff and visitors to wash their hands or use an alcohol-based hand sanitizer before touching you. Ask care providers to wipe stethoscopes and other equipment with alcohol. Don't set food or utensils directly on tables or beds. Make sure that intravenous tubes and catheters are inserted under sterile conditions.

Benefits of Broad Genetic Testing Still Limited

Five years ago, scientists finished mapping the complete human genetic code, but genetic assessment of disease risk remains in its infancy, according to the June issue of Mayo Clinic Women's HealthSource.

Scientists know that people share essentially the same genetic makeup, differing only by one-tenth of 1 percent. By studying that small variation, they hope to explain why one person is healthy and another sick and which treatments are best suited for each individual.

Scientists have identified "simple" genetic disorders caused by mutation of a single gene, for example, sickle cell anemia. Much more research is necessary on common diseases such as cancer, heart disease and d
'/>"/>

SOURCE Mayo Clinic
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 Tianyin Pharmaceutical Co., Inc. ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today updates the timeline for the ... The Company is scheduled to ... China Food & Drug Administration,s (CFDA) review in ...
(Date:8/28/2014)... -- Levi & Korsinsky announces that a class action ... Court for the District of Nevada ... Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities between ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt . ... the Company violated federal securities laws by issuing false ...
(Date:8/28/2014)... , August 28, 2014 ... "DNA diagnostics Market (products, applications, techniques, end users ... Growth and Forecast, 2013 - 2020," indicates that ... billion by 2020 registering a CAGR of 9.8% ... accurate diagnosis and cost effectiveness over alternative diagnostic ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
... 5, 2011 SyncMedical LLC today announced ... – Brazilian National Health Surveillance Agency) has approved their ... in Brazil. SyncMedical,s Ethos Spine product line was developed ... treatment solutions to surgeons in the ever-growing, ever-changing field ...
... Jan. 5, 2011 Heska Corporation (Nasdaq: HSKA ... Conference hosted by Sidoti & Company, LLC on Monday, January ... 42nd Street (Park Avenue at Grand Central) in New York ... Eastern Time. (Logo:   http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) ...
Cached Medicine Technology:SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil 2
(Date:8/29/2014)... (PRWEB) August 29, 2014 Scientists from ... idea that progression-free survival correlates with overall survival of ... the new research. Click here to read it ... The Netherlands studied the cases of 523 mesothelioma ... studies. , “PFSR-18 [progression-free survival at 18 weeks ...
(Date:8/29/2014)... 2014 Edvance360, a leading provider of ... online teaching, as well as 2011 winner and six-time-finalist ... Management System, announced that their CTO, Brian Gerrity, and ... ALS Ice Bucket Challenge on behalf of Edvance360 Corporate ... Co-Founder. , “We know that the options were to ...
(Date:8/29/2014)... August 2014: A new ESC journal on cardiovascular pharmacotherapy ... and Oxford University Press. , European Heart Journal ... A special launch issue has been produced for ESC ... The journal,s website goes live in September. , Editor ... become the number one journal in the field of ...
(Date:8/29/2014)... When it comes to marketing, it’s important to create ... of MD Marketing Experts, is offering his expertise to ... and speaking events, while his company keeps on launching ... firm of medical marketing consultants, providing an all in ... strategies like web design, search engine optimization (SEO), pay-per-click ...
(Date:8/29/2014)... Today, Fecbek, a well-known female boots manufacturer and retailer, ... boots. The new items are offered in many styles, including ... All these products are nice-looking and elegant with the latest ... clients. , A boot is a type of footwear and ... foot and the ankle and extend up the leg, sometimes ...
Breaking Medicine News(10 mins):Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2Health News:Edvance360 Participates In the ALS Ice Bucket Challenge (#ALSicebucketchallenge) 2Health News:ESC launches journal on CV pharmacotherapy 2Health News:MD Marketing Experts Evolution – Motivational Speaking, Workshops and New Websites Launch 2Health News:MD Marketing Experts Evolution – Motivational Speaking, Workshops and New Websites Launch 3Health News:Nice Boots for Sale at Fecbek.com 2
... Chemical compounds specially designed to neutralize proteins that would ... recognized for some time by scientists as a promising ... the November 16, 2007 issue of the journal Cell, ... how these antagonists of the anti-deathso-called Inhibitor-of-Apoptosis (IAP)proteins work ...
... year due to ... lung cancer --, -- More than 50% of new patients have ... according to the Lung Cancer Alliance --, ... early cancer detection, and The Thomas,G. Labrecque Foundation, a nonprofit organization that funds lung ...
... today announced that its Audit Committee has ... external auditors, that a,deemed dividend of $1,576,454 ... the Company,s financial statements by recording a ... in the consolidated,statement of operations for the ...
... sensing technologies have made exquisite measurements of brain ... measurements, computer scientists will now help neuroscientists discover ... result in the actions we take for granted, ... General Motors (GM) officials visited the Virginia Tech ...
... London, UK, 15 November, 2007 Reproductive Health Matters and ... Issue devoted to the celebration of the twentieth anniversary of ... in 1987. The November issue responds to the question ... yes − and no. , Globally, ...
... People who have experienced,the death of a ... dread.,Long-standing family traditions will never be the same; ... are replaced by depression and,loneliness. GriefShare, an ... a special "Surviving the Holidays" website to offer ...
Cached Medicine News:Health News:How 'IAP antagonist' chemicals kill tumors 2Health News:Canary Foundation and the Thomas G. Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 2Health News:Canary Foundation and the Thomas G. Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 3Health News:Canary Foundation and the Thomas G. Labrecque Foundation Launch a New Lung Cancer Early Detection Initiative 4Health News:Health Fitness Announces Non-Cash Adjustment and Restatement of 2006 Equity Investment Transaction Resulting in Delay for Filing Third Quarter Form 10-Q 2Health News:General Motors, Virginia Tech scientists collaborate to advance neuroinformatics 2Health News:General Motors, Virginia Tech scientists collaborate to advance neuroinformatics 3Health News:General Motors, Virginia Tech scientists collaborate to advance neuroinformatics 4Health News:November issue of Reproductive Health Matters focuses on maternal mortality 2Health News:Surviving the Holidays after a Loved One's Death 2
... designed to prevent lower body exposure to scattered ... any table where X-ray fluoroscopy is used. These ... applications where C-arm fluoroscopy units are used. Three ... each equipped with a 17 cm wide mounting ...
Pregnancy Apron...
All Day Comfort for the Lower Body...
Designed for special procedures, this Wrap-Around apron has .50mm Pb in the front and .25mm Pb in the back. The velcro fasteners are adjustable to provide the most comfortable fit....
Medicine Products: